Page last updated: 2024-11-02

pantoprazole and Neuroendocrine Tumors

pantoprazole has been researched along with Neuroendocrine Tumors in 1 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corsello, A1
Di Filippo, L1
Massironi, S1
Sileo, F1
Dolcetta Capuzzo, A1
Gemma, M1
Carlucci, C1
Cusini, C1
Colombo, B1
Dallatomasina, A1
Franchi, GM1
Corti, A1
Manzoni, MF1

Other Studies

1 other study available for pantoprazole and Neuroendocrine Tumors

ArticleYear
Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms.
    PloS one, 2018, Volume: 13, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Antineoplastic Agents; Area Under Curve; Biomarkers,

2018